Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
1.845
+0.015 (0.82%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $80.39 million as of April 17, 2025. Its market cap has decreased by -91.49% in one year.
Market Cap
80.39M
Enterprise Value
-197.35M
1-Year Change
-91.49%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $80.39M, a decrease of -91.05%. That is a compound annual growth rate of -86.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 80.39M | -50.21% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |